Oncology & Cancer

Genes reveal kidney cancer's risk of recurrence

Studying the mutations in kidney cancer after surgery could help to better predict the risk of the disease coming back, according to the latest results of a decade-long international study.

Medications

Study finds 'startling' inequities in end-of-life opioid treatment

Older Black and Hispanic patients with advanced cancer are less likely than white patients to receive opioid medications for pain relief in the last weeks of life, according to a study led by investigators at Harvard-affiliated ...

page 6 from 29